K250997

Substantially Equivalent

Integrity Implant

Applicant: Anika Therapeutics, Inc.
Product code: OWX
Advisory panel: General, Plastic Surgery
Date received: 2025-04-01
Decision date: 2025-06-17
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Beford, MA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.